杨鹏｜中国药科大学｜学者主页

2026

Yang Pan, Dai-Tao Zhang, Peng Yang, Leo L. M. Poon, Quan-Yi Wang

Lancet. Infectious Diseases (Print)

DOI

2020

The incidence rate and hospitalization rate of seasonal influenza in Beijing, 2018-2019

Dai-Tao Zhang, Zhongcheng Liu, Xiao-Juan Zhao, Yi Zhang, Peng Yang, Quan-Yi Wang

DOI

2020

8-year M type surveillance of Streptococcus pyogenes in China.

Yuanhai You, Xiao-min Peng, Peng Yang, Quan-Yi Wang, Jian-Zhong Zhang

Lancet. Infectious Diseases (Print)

DOI

2020

Influenza-associated cardiovascular mortality in older adults in Beijing, China: a population-based time-series study

Zhi-Bin Peng, Da-Yan Wang, Juan Yang, Peng Yang, Yan-Yang Zhang, Jian Chen, Tao Chen, Yaming Zheng, Jian-Dong Zheng, Shi-Qiang Jiang, Li-Li Xu, M. Kang, Ying Qin, Meng-Miao Zhao, Zhong-Jie Li, Lu-Zhao Feng

Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi

DOI

2018

Yang Pan, Peng Yang, T. Dong, Yi Zhang, Wei-xian Shi, Xiao-min Peng, S. Cui, Dai-Tao Zhang, Gui-Lan Lu, Yi-meng Liu, Shuang-Sheng Wu, Quan-Yi Wang

Frontiers in Cellular and Infection Microbiology

DOI

2017

DOI

2016

Potential Roles of Protease Inhibitors in Cancer Progression.

Peng Yang, Zhuo-Yu Li, Han-Qing Li

Asian Pacific Journal of Cancer Prevention

DOI

2016

Prognostic value of POSTN in human cancer : a meta-analysis

Peng Yang, Jie Wang, Zipeng Xu, Tao Chen, Zhen-Yu He

2016

Elevated expression of long noncoding RNA UCA 1 can predict a poor prognosis : a meta-analysis

Tao Chen, Peng Yang, Zhen-Yu He

2016

MiR-106b-mediated Mfn2 suppression is critical for PKM2 induced mitochondrial fusion.

Hai-Li Wu, Zhuo-Yu Li, Ying-Ying Wang, Peng Yang, Zong-Rui Li, Han-Qing Li, Changxing Wu

American Journal of Cancer Research

2016

A. Chughtai, C. R. MacIntyre, M. Ashraf, Yang Zheng, Peng Yang, Quan-Yi Wang, T. Dũng, Hien T. Nguyen, H. Seale

American Journal of Infection Control

DOI

2015

Peng Yang, X. Pang, Yi Zhang, Xiao-Li Wang, Dai-Tao Zhang, Hai-Kun Qian, Quan-Yi Wang

Journal of Infection

DOI

2014

W. Duan, Peng Yang, Wei-xian Shi, Xiao-min Peng, Hui-jie Liang, Quan-Yi Wang

DOI

2014

Influenza vaccine effectiveness against medically-attended influenza illness during the 2012-2013 season in Beijing, China.

Peng Yang, M. Thompson, Chun-Na Ma, Wei-xian Shi, Shuang-Sheng Wu, Dai-Tao Zhang, Quan-Yi Wang

Vaccine

DOI

2014

Corrigendum to “Efficacy of face masks and respirators in preventing upper respiratory tract bacterial colonization and co-infection in hospital healthcare workers” [Prev. Med. 62 (2014) 1–7]

C. R. MacIntyre, Quan-Yi Wang, Bayzidur Rahman, H. Seale, I. Ridda, Zhan-Hai Gao, Peng Yang, Wei-xian Shi, X. Pang, Yi Zhang, Aye M. Moa, D. Dwyer

DOI

2013

Preparation method and application of colon cancer cell strain expressed by stabilized silent PKM2 gene

Zhuo-Yu Li, Hai-Li Wu, Zong-Wei Li, Peng Yang

2013

A probable food-borne outbreak of pharyngitis after a massive rainstorm in Beijing, caused by emm89 group A Streptococcus rarely found in China.

Peng Yang, Xiao-min Peng, Jun-Yong Yang, Xiao-Gen Dong, Man Zhang, Quan-Yi Wang

International Journal of Infectious Diseases

DOI

2012

[Analysis of status and influence factors of health literacy related to infectious diseases in residents of Beijing].

Shuang-Sheng Wu, Peng Yang, Hai-Yue Li, Chun-Na Ma, Yi Zhang, Quan-Yi Wang

Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences

2012

Seroprevalence of pandemic (H1N1) 2009 influenza and effectiveness of 2010/2011 influenza vaccine during 2010/2011 season in Beijing, China

Peng Yang, Li Zhang, Wei-xian Shi, Gui-Lan Lu, S. Cui, Xiao-min Peng, Dai-Tao Zhang, Yi-meng Liu, Hui-jie Liang, X. Pang, Quan-Yi Wang

Influenza and Other Respiratory Viruses

DOI

2012

Shuang-Sheng Wu, Peng Yang, Hai-Yue Li, Chun-Na Ma, Yi Zhang, Xin-Yu Li, Quan-Yi Wang

DOI

2012

Shuang-Sheng Wu, Peng Yang, Xiao-Li Wang, Yi Zhang, Li Zhang, W. Duan, Yang Zheng, Quan-Yi Wang

DOI

2011

A post-pandemic survey on knowledge, practice and skill related to influenza in the general population of Beijing

Peng Yang, Shuang-Sheng Wu, Hai-Yue Li, Chun-Na Ma, Yi Zhang, Li Zhang, Xin-Yu Li, Quan-Yi Wang

DOI

2011

[Epidemiological characteristics of infection for close contacts of pandemic (H1N1) 2009 in Beijing].

X. Pang, Peng Yang, Shuang Li, Li Zhang, L. Tian, Yang Li, Bo Liu, Yi Zhang, Bai-Wei Liu, Ruo-Gang Huang, Xin-Yu Li, Quan-Yi Wang

Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases

DOI

2011

The clinical application of real-Time PCR,colloidal gold rapid test and virus isolation in diagnosis of influenza A virus

Wei-xian Shi, Fang Huang, Shu-Juan Cui, Xiao-min Peng, Lyu Yanning, Hui-jie Liang, Hai-Kun Qian, Yi Zhang, W. Duan, Peng Yang, Quan-Yi Wang

2011

Investigation of the first Chikungunya fever case in Beijing

L. Tian, Tingkai Liu, Peng Yang, Xin-Yu Li, X. Dou, Xiao-Mei Wang, Zhan-Ying He, Zeng-Zhi Guan, Xu Li, Hai-Lin Ren, Yang-Hua Li, Quan-Yi Wang

DOI

2011

Serological surveillance of 2009 H1N1 influenza in China.

Peng Yang, Wei-xian Shi, L. Tian, Shuang Li, Li Zhang, Fang Huang, Quan-Yi Wang

Hai-Kun Qian, Peng Yang, Yi Zhang, Xiao-Li Wang, Shuang Li, Bai-Wei Liu, Zhan-Ying He, Xi-Tai Li, L. Jia, Xin-Yu Li, Quan-Yi Wang

DOI

Yi Zhang, Peng Yang, Xiao-Li Wang, Wen-Ting Liu, Quan-Yi Wang, C. R. Maclntyre, H. Seale, SimonCauchemez, N. Ferguson

DOI

2011

A cluster randomized clinical trial comparing fit‐tested and non‐fit‐tested N95 respirators to medical masks to prevent respiratory virus infection in health care workers

C. R. MacIntyre, Quan-Yi Wang, S. Cauchemez, H. Seale, D. Dwyer, Peng Yang, Wei-xian Shi, Zhan-Hai Gao, X. Pang, Yi Zhang, Xiao-Li Wang, W. Duan, Bayzidur Rahman, N. Ferguson

Influenza and Other Respiratory Viruses

DOI

2011

[The coverage rate and obstructive factors of influenza vaccine inoculation among residents aged above 18 years in Beijing from 2007 to 2010].

Shuang-Sheng Wu, Peng Yang, Hai-Yue Li, Chun-Na Ma, Yi Zhang, Quan-Yi Wang

Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]

DOI

2011

Li Zhang, L. Tian, Peng Yang, Yi Zhang, Bo Liu, Yang Li, Shuang Li, Bai-Wei Liu, Xin-Yu Li, Ying Deng, X. Pang, Quan-Yi Wang

DOI

2010

[Estimation on the real number of novel influenza A (H1N1) cases, Beijing, 2009].

Xiao-Li Wang, Peng Yang, X. Dou, Yi Zhang, Wen-Ting Liu, Ying Deng, X. Pang, Xiong He, Quan-Yi Wang

Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi

DOI

2010

Seasonal influenza vaccine supply and target vaccinated population in China, 2004-2009.

Lu-Zhao Feng, A. Mounts, Yun-Xia Feng, Yuan Luo, Peng Yang, Zi-Jian Feng, Wei-Zhong Yang, Hong-Jie Yu

Vaccine

DOI

Xin-Yu Li, Ting Gao, Peng Yang, Quan-Yi Wang, X. Pang

DOI

2010

[A survey on serological epidemiology of influenza A (H1N1) 2009 in Beijing].

Peng Yang, Fang Huang, Wei-xian Shi, Gui-Lan Lu, L. Tian, Shu-Juan Cui, Xin Zhang, Shuang Li, Bai-Wei Liu, Ying Deng, X. Pang, Quan-Yi Wang

Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi

DOI

2010

Estimates of the True Number of Cases of Pandemic (H1N1) 2009, Beijing, China

Xiao-Li Wang, Peng Yang, H. Seale, Yi Zhang, Ying Deng, X. Pang, Xiong He, Quan-Yi Wang

Emerging Infectious Diseases

DOI

2010

[Epidemiology of travel-associated influenza A (H1N1) 2009 infection in Beijing].

Yi Zhang, Ying Deng, Xing-huo Pany, Peng Yang, L. Tian, Yang Li, Bo Liu, Li Zhang, Bai-Wei Liu, Quan-Yi Wang

Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi

DOI

Hua Wang, Zi-Jian Feng, Y. Shu, Hong-Jie Yu, Lei Zhou, R. Zu, Yang Huai, Jie Dong, C. Bao, L. Wen, Hong Wang, Peng Yang, Wei Zhao, Libo Dong, Ming-Hao Zhou, Q. Liao, Hai-Tao Yang, Min Wang, Xiaojun Lu, Zhiyang Shi, Wei Wang, Ling Gu, F. Zhu, Qun Li, W. Yin, Wei-Zhong Yang, De-Xin Li, T. Uyeki, Yu Wang

The Lancet

DOI

精选作品

期刊论文

TRIM家族蛋白的功能及结构域调控分子研究进展

Medicinal Chemistry Strategies for Targeting RNA-Binding Proteins: Design, Optimization, and Therapeutic Potential

A Multifunctional Prodrug with the DNA Damage Amplification Effect for Inducing Immunogenic Cell Death

Rational Design of Potent and Orally Efficacious PI3Kα/δ Degrader for PIK3CA Mutant Breast Cancer without Hyperglycemic Liability

Rational Design of Imidazo[1,2- a ]pyridine as an Effective TLR7 Antagonist for the Treatment of Psoriasis: Research Combined with In Silico Study

Discovery of Novel, Potent, and Selective IRAK1 Inhibitors as Potential Therapeutics for Hepatocellular Carcinoma

TIM-3 Inhibitor Development: Overcoming Immune Evasion in Cancer Therapy

Preclinical Efficacy of TSL2109 in Prostate Cancer Treatment and Overcoming Enzalutamide Resistance

From concept to application: Exploring the evolution and potential of DUBTAC technology

Structure-Guided Design of a Highly Selective PI3Kα Inhibitor Overcoming Metabolic Dysregulation with Potent Anti-breast Cancer Efficacy

Targeting Protein Tyrosine Phosphatase Nonreceptor Type 2 with a Novel Inhibitor for the Treatment of Melanoma

Call for Papers: Pharmaceutical Innovation and Global Health: Breakthroughs and Future─Celebrating the 90th Anniversary of China Pharmaceutical University

Development of Novel PTPN2/1 Inhibitors for the Treatment of Melanoma

Design, Synthesis, and Activity Evaluation of Novel Nucleosides as ADAR1 Inhibitor for the Treatment of Prostate Cancer

ASO Therapy Targeting STAU2 to Inhibit Pancreatic Ductal Adenocarcinoma Progression and Metastasis by Regulating the PALLD‐Mediated EMT Signaling Pathway

Discovery of a Novel and Potent MET Transcription Inhibitor Targeting Promoter G-Quadruplex for the Treatment of NSCLC

Development of Novel PRMT7 Inhibitors for the Treatment of Prostate Cancer

Discovery of potent and selective CDK2 inhibitors with high safety and favorable bioavailability for the treatment of cancer

Carbonic anhydrase IX-targeted SMDCs for cancer precision treatment

Recent advances in regulating the cell cycle through inhibiting CDKs for cancer treatment

Targeting ADAR1 with a small molecule for the treatment of prostate cancer

Discovery of Novel Small-Molecule Inhibitors Disrupting the MTDH-SND1 Protein–Protein Interaction

Novel PD-L1/VISTA Dual Inhibitor as Potential Immunotherapy Agents

ADAR1 is required for acute myeloid leukemia cell survival by modulating post-transcriptional Wnt signaling through impairing miRNA biogenesis

Regulation of protein phosphorylation by PTPN2 and its small-molecule inhibitors/degraders as a potential disease treatment strategy

Discovery of Potent and Selective c-Met Degraders for Hepatocellular Carcinoma Treatment

Design, Synthesis, and Biological Evaluation of Novel EGFR PROTACs Targeting C797S Mutation

Design, Synthesis, and Antitumor Activity Evaluation of Novel VISTA Small Molecule Inhibitors

Molecules Inducing Specific Cyclin-Dependent Kinase Degradation and their Possible Use in Cancer Therapy

Comprehensive analyses reveal molecular and clinical characteristics of RNA modification writers across 32 cancer types

Spatio-temporal distribution and influencing factors of norovirus outbreaks in Beijing, China from 2016 to 2020

Clinical, epidemiological, and virological features of Mpox in Beijing, China – May 31–June 21, 2023

Acute gastroenteritis outbreaks caused by human astrovirus, 1978–2021: A systematic review

Occurrence of respiratory viruses among outpatients with diarrhea in Beijing, China, 2019–2020

Using an influenza surveillance system to estimate the number of SARS-CoV-2 infections in Beijing, China, weeks 2 to 6 2023

Discovery of potent and selective c-Met inhibitors for MET-amplified hepatocellular carcinoma treatment

Discovery of Potent, Selective, and Orally Bioavailable DYRK2 Inhibitors for the Treatment of Prostate Cancer

Highly potent dual-targeting angiotensin-converting enzyme 2 (ACE2) and Neuropilin-1 (NRP1) peptides: A promising broad-spectrum therapeutic strategy against SARS-CoV-2 infection

Discovery of Novel Fourth-Generation EGFR Inhibitors to Overcome C797S-Mediated Resistance

Targeting polyketide synthase 13 for the treatment of tuberculosis

Development of Biaryl-Containing Aldo-Keto Reductase 1C3 (AKR1C3) Inhibitors for Reversing AKR1C3-Mediated Drug Resistance in Cancer Treatment

Bispecific antibodies in cancer therapy: Target selection and regulatory requirements

Discovery of Potent and Wild-Type-Sparing Fourth-Generation EGFR Inhibitors for Treatment of Osimertinib-Resistance NSCLC

Discovery of Potent DYRK2 Inhibitors with High Selectivity, Great Solubility, and Excellent Safety Properties for the Treatment of Prostate Cancer

Expanding role of CXCR2 and therapeutic potential of CXCR2 antagonists in inflammatory diseases and cancers

Avenanthramide C induces cellular senescence in colorectal cancer cells via suppressing β-catenin-mediated the transcription of miR-183/96/182 cluster.

Cucurbitacin E Triggers Cellular Senescence in Colon Cancer Cells via Regulating the miR-371b-5p/TFAP4 Signaling Pathway.

Importation of SARS-CoV-2 Omicron variant in Beijing, China

An Updated Review on SARS-CoV-2 Infection in Animals

Genomic characteristics of SARS-CoV-2 in Beijing, China, 2021

Interruption of influenza transmission under public health emergency response for COVID-19 based on real-world data, Beijing, China.

Application of a ddRT-PCR to quantify seasonal influenza virus for viral isolation

Genomic, immunological, and clinical analysis of COVID‐19 vaccine breakthrough infections in Beijing, China

Virus Isolation and Propagation from H3N2 Influenza Infected Human Clinical Samples Under Distinct Sample Storage Conditions

A Local Cluster of Omicron Variant COVID-19 Likely Caused by Internationally Mailed Document — Beijing Municipality, China, January 2022

Detection by environmental surveillance and genomic characterization of H5N8 highly pathogenic avian influenza virus from a poultry meat market in Beijing, China, 2021–22

Novel Small-Molecule PD-L1 Inhibitor Induces PD-L1 Internalization and Optimizes the Immune Microenvironment

Development of highly potent and specific AKR1C3 inhibitors to restore the chemosensitivity of drug-resistant breast cancer

Discovery, Optimization, and Evaluation of Selective CDK4/6 Inhibitors for the Treatment of Breast Cancer

Pan-cancer analysis of DNA methyltransferase family with potential implications in prognosis and immunology in human cancer

Systematic Identification of the RNA-Binding Protein STAU2 as a Key Regulator of Pancreatic Adenocarcinoma

Discovery of Novel Phosphoinositide-3-Kinase α Inhibitors with High Selectivity, Excellent Bioavailability, and Long-Acting Efficacy for Gastric Cancer

Targeting dual-specificity tyrosine phosphorylation-regulated kinase 2 with a highly selective inhibitor for the treatment of prostate cancer

Overcoming Mycobacterium tuberculosis through small molecule inhibitors to break down cell wall synthesis

Novel phthalimides regulating PD-1/PD-L1 interaction as potential immunotherapy agents

PTPN2, A Key Predictor of Prognosis for Pancreatic Adenocarcinoma, Significantly Regulates Cell Cycles, Apoptosis, and Metastasis

LncRNA SNHG14 promotes cell proliferation and invasion in colorectal cancer through modulating miR-519b-3p/DDX5 axis

Hypoxic colorectal cancer‐derived extracellular vesicles deliver microRNA‐361‐3p to facilitate cell proliferation by targeting TRAF3 via the noncanonical NF‐κB pathways

Hsa_circ_0001666 suppresses the progression of colorectal cancer through the miR‐576‐5p/PCDH10 axis

Cetuximab functionalization strategy for combining active targeting and antimigration capacities of a hybrid composite nanoplatform applied to deliver 5-fluorouracil: toward colorectal cancer treatment.

First Human Infection Case of Monkey B Virus Identified in China, 2021

Impact of RNA degradation on influenza diagnosis in the surveillance system.

Coronavirus disease 2019 outbreak in Beijing’s Xinfadi Market, China: a modeling study to inform future resurgence response

Discovery of Dual CDK6/PIM1 Inhibitors with a Novel Structure, High Potency, and Favorable Druggability for the Treatment of Acute Myeloid Leukemia

Development and clinical advancement of small molecules for ex vivo expansion of hematopoietic stem cell

Corrigendum to “Design, synthesis, and biological evaluation of novel tetrahydroprotoberberine derivatives to reduce SREBPs expression for the treatment of hyperlipidemia” [Eur. J. Med. Chem. 221 (2021) 113522]

Discovery of novel and orally bioavailable CDK 4/6 inhibitors with high kinome selectivity, low toxicity and long-acting stability for the treatment of multiple myeloma

Design, Synthesis, and Biological Evaluation of Icaritin Derivatives as Novel Putative DEPTOR Inhibitors for Multiple Myeloma Treatment